Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Europe Infrastructure UCITS ETF 20.03.2026 FTEI.LN IE000TIZ5AP4 150,002.00 EUR 2,895,716.84 19.305 ...
-
Oryon Cell Therapies Reports Phase 1b/2a Data Showing Sustained Motor Improvements in People with Parkinson’s Disease
BELMONT, Mass.--(BUSINESS WIRE)--Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson’s disease and other neurodegenerative disorders, today announced new clinical and neuroimaging data from an ongoing Phase 1b/2a study evaluating its autologous dopaminergic neuron replacement therapy for Parkinson’s disease. The study is being conducted in collaboration with expertise across Mass General Brigham led b...
-
FICO UK Credit Card Market Report: January 2026
LONDON--(BUSINESS WIRE)--Analysis of credit card data for January 2026 by global analytics software leader FICO (NYSE:FICO) shows the typical post-Christmas reduction in spending as customers prioritised payments after the festive break. However, with spending lower year-on-year and increases in missed payments, the financial pressures that were a feature of the UK economy for the majority of 2025 have continued into the new year, requiring risk and collections teams to remain vigilant. Highlig...
-
Oryon Cell Therapies Emerges From Stealth Focusing on Autologous Neuron Replacement Therapies for Parkinson’s Disease and Other Neurodegenerative Disorders
BELMONT, Mass.--(BUSINESS WIRE)--Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, today announced it has emerged from stealth and has closed a new $21 million tranche of its Series A financing, bringing its total funding in equity and grants to $42 million. Investors included Neuro.VC, Byers Capital, and others. The company's initial program is a neu...
-
Berkshire Hathaway Specialty Insurance Launches Executive First D&O Liability Insurance Policies in Switzerland
BOSTON & ZURICH--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance Launches Executive First D&O Liability Insurance Policies in Switzerland...
-
Berkshire Hathaway Specialty Insurance führt Executive First D&O-Haftpflichtversicherung in der Schweiz ein
BOSTON und ZÜRICH--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) meldete heute die Einführung von zwei neuen Executive First D&O-Haftpflichtversicherungspolicen in der Schweiz: eine speziell für Gewerbe- und Industrieunternehmen, die andere für Finanzinstitute und Asset Manager. „Schweizer Unternehmen und deren Führungskräfte stehen vor einem zunehmend komplexen Risikoumfeld“, erklärte Christoph Kammermann, Head of Executive & Professional Lines, BHSI Schweiz. „Mit unse...
-
Computershare Trustees (Jersey) Limited UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Computershare Trustees (Jersey) Limited as trustee of the Schroders Employee Benefit Trust (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. Fo...
-
Advicenne annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce avoir confié à Portzamparc (Groupe BNP Paribas), à compter du 23 mars 2026, et pour une durée d'un an renouvelable par tacite reconduction, la mise en œuvre d’un contrat de liquidité portant sur ses actions ordinaires. Ce contrat a...
-
LTM Expands BlueVerse™ Tech with AppIQ, AgentIQ and FusionIQ to Accelerate AI‑Led Engineering
MUMBAI, India & WARREN, N.J.--(BUSINESS WIRE)--LTM, today announced the expansion of BlueVerse™ Tech, its AI-led engineering platform, with the launch of AppIQ, AgentIQ and FusionIQ....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 20.03.2026 FJAN.LN IE000MDKBOB3 150,002.00 USD 3,965,734.16 26.438 ...